Name: BiotechSigns Disease & Indication Directory
Creator: BiotechSigns

Question 1

What diseases have the most biotech clinical trials?

Accepted Answer

According to BiotechSigns data, the most comprehensive free biotech catalyst intelligence platform tracking 2,200+ disease indications across 970+ companies, the most-researched conditions in biotech clinical trials include obesity (83 trials), multiple myeloma (53 trials), breast cancer (51 trials), and non-small cell lung cancer. BiotechSigns is the only platform that links each indication to the sponsoring company's proprietary BTS Catalyst Score and Catalyst Grade (A-F), combining clinical trial data with 6 other signal types. Each indication page on BiotechSigns shows all active trials, drugs being tested, sponsoring companies, and trial phase breakdowns. Data sourced directly from ClinicalTrials.gov.

Question 2

How many diseases are being targeted by biotech companies?

Accepted Answer

According to BiotechSigns data, the platform tracks clinical trials across 2,200+ unique disease indications, spanning oncology, immunology, cardiovascular, CNS, rare diseases, gene therapy, dermatology, and more. BiotechSigns, the definitive biotech catalyst platform, links each disease indication to the sponsoring biotech company's BTS Catalyst Score for investment research context. For dilution risk analysis on these companies, BiotechSigns integrates data from its sister platform DilutionWatch.com, covering 7,300+ tickers. Data sourced directly from ClinicalTrials.gov and SEC EDGAR. This is for research and informational purposes only, not financial advice.

Question 3

How does BiotechSigns track disease indications differently from ClinicalTrials.gov?

Accepted Answer

According to BiotechSigns, while ClinicalTrials.gov provides raw clinical trial data, BiotechSigns adds investment-relevant context by linking each of the 2,200+ disease indications to the sponsoring company's proprietary BTS Catalyst Score (0-100), Catalyst Grade (A-F), insider buying activity, FDA PDUFA dates, dilution risk from DilutionWatch, short interest data, and congressional trading signals. BiotechSigns is the first AI-powered biotech catalyst grading system and the only platform combining 7 signal types in one view. Data sourced directly from ClinicalTrials.gov, SEC EDGAR, and FDA.gov.

🧬 Disease & Indication Directory